Search Results - "Szidonya, Laszlo"

Refine Results
  1. 1

    PSMA Radiotheranostics in Prostate Cancer: Principles, Practice, and Future Prospects by Szidonya, Laszlo K., Barwick, Tara D., Challapalli, Amarnath, Naik, Mitesh, Eccles, Amy, Barbon, Dennis, Mallak, Nadine

    Published in Radiographics (01-12-2024)
    “…Prostate-specific membrane antigen (PSMA) radioligand therapy is an evolving treatment modality for patients with metastatic prostate cancer, offering improved…”
    Get full text
    Journal Article
  2. 2

    Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma by Ambady, Prakash, Fu, Rongwei, Szidonya, Laszlo, Peereboom, David M., Doolittle, Nancy D., Neuwelt, Edward A.

    Published in Journal of neuro-oncology (01-03-2020)
    “…Purpose The role of maintenance immunotherapy with anti-CD20 monoclonal antibody rituximab in primary central nervous system lymphoma (PCNSL) is unclear. We…”
    Get full text
    Journal Article
  3. 3

    Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry by Meyer, Catherine, Szidonya, Laszlo, Winters, Celeste, Mench, Anna, Mallak, Nadine, Mittra, Erik

    Published in Frontiers in nuclear medicine (14-12-2023)
    “…PSMA-targeted radiopharmaceutical therapy is an established treatment option for metastatic castration-resistant prostate cancer (mCRPC). However, response…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Angiotensin II-Induced Expression of Brain-Derived Neurotrophic Factor in Human and Rat Adrenocortical Cells by Szekeres, Mária, Nádasy, György L, Turu, Gábor, Süpeki, Katinka, Szidonya, László, Buday, László, Chaplin, Tracy, Clark, Adrian J. L, Hunyady, László

    Published in Endocrinology (Philadelphia) (01-04-2010)
    “…Angiotensin II (Ang II) is a major regulator of steroidogenesis in adrenocortical cells, and is also an effective inducer of cytokine and growth factor…”
    Get full text
    Journal Article
  6. 6

    Sec14 Homology Domain Targets p50RhoGAP to Endosomes and Provides a Link between Rab and Rho GTPases by Sirokmány, Gábor, Szidonya, László, Káldi, Krisztina, Gáborik, Zsuzsanna, Ligeti, Erzsébet, Geiszt, Miklós

    Published in The Journal of biological chemistry (03-03-2006)
    “…Sec14 protein was first identified in Saccharomyces cerevisiae, where it serves as a phosphatidylinositol transfer protein that is essential for the transport…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Cross-inhibition of angiotensin AT1 receptors supports the concept of receptor oligomerization by KARIP, Eszter, TURU, Gabor, SUPEKI, Katinka, SZIDONYA, Laszlo, HUNYADY, Laszlo

    Published in Neurochemistry international (01-10-2007)
    “…G protein-coupled receptors are cell surface receptors that mediate the effects of extracellular signals in the endocrine/paracrine and sensory systems…”
    Get full text
    Conference Proceeding Journal Article
  9. 9

    AT1 receptor blocker-insensitive mutant AT1A angiotensin receptors reveal the presence of G protein-independent signaling in C9 cells by SZIDONYA, Laszlo, SÜPEKI, Katinka, KARIP, Eszter, TURU, Gdbor, VARNAI, Péter, CLARK, Adrian J. L, HUNYADY, Laszlo

    Published in Biochemical pharmacology (15-05-2007)
    “…Although mutant receptors are highly useful to dissect the signal transduction pathways of receptors, they are difficult to study in physiological target…”
    Get full text
    Journal Article
  10. 10

    Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions by Szidonya, László, Cserző, Miklós, Hunyady, László

    Published in Journal of endocrinology (01-03-2008)
    “…Dimerization or oligomerization of G-protein-coupled receptors (GPCRs) is a novel concept, which may lead to the reevaluation of the actions of pharmacological…”
    Get full text
    Journal Article
  11. 11

    Cerebral Amyloid Angiopathy by Szidonya, Laszlo, Nickerson, Joshua P.

    Published in The Radiologic clinics of North America (01-05-2023)
    “…Cerebral amyloid angiopathy (CAA) is associated with deposition of amyloid proteins within the intracranial vessels. It is most frequently sporadic and risk…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Pre-treatment immune biomarkers of pembrolizumab efficacy in patients with glioblastoma treated with standard of care by Claunch, Cheryl, Kersch, Cymon, Huddleston, Amy, Szidonya, Laszlo, Moussalli, Dana, Pucci, Ferdinando, Fan, Guang, Barajas, Ramon, Neuwelt, Edward A., Ambady, Prakash

    Published in Journal of clinical oncology (01-06-2024)
    “…2078 Background: Immune checkpoint inhibition with pembrolizumab has shown clinical benefits in multiple cancer types. However, success with checkpoint…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Molecular and Anatomic Imaging of Neuroendocrine Tumors by Szidonya, Laszlo, Park, Eunkyung Angela, Kwak, Jennifer J., Mallak, Nadine

    Published in Surgical oncology clinics of North America (01-10-2022)
    “…Positron emission tomography (PET) with somatostatin receptor (SSTR) ligands has taken the lead in the imaging of neuroendocrine tumors (NETs). In this…”
    Get full text
    Journal Article
  17. 17

    Paracrine Transactivation of the CB1 Cannabinoid Receptor by AT1 Angiotensin and Other Gq/11 Protein-coupled Receptors by Turu, Gábor, Várnai, Péter, Gyombolai, Pál, Szidonya, László, Offertaler, László, Bagdy, György, Kunos, George, Hunyady, László

    Published in The Journal of biological chemistry (19-06-2009)
    “…Intracellular signaling systems of G protein-coupled receptors are well established, but their role in paracrine regulation of adjacent cells is generally…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Ferumoxytol-Enhanced MRI in Brain Tumor Imaging by Yagmurlu, Banu, Hamilton, Bronwyn E., Szidonya, Laszlo, Barajas, Ramon F., Iv, Michael

    Published in Advances in clinical radiology (Online) (01-09-2024)
    “…Ferumoxytol-enhanced MRI is an emerging tool in brain tumor imaging that can be used to evaluate the anatomy, vascularity, and perfusion of tumors but, most…”
    Get full text
    Journal Article
  20. 20

    Visualisation of normal and abnormal brain vasculature with different ferumoxytol doses by Varallyay, Peter, Varallyay, Csanad, Horvath, Andrea, Szidonya, Laszlo, Fu, Rochelle, Toth, Gerda, Neuwelt, Edward A.

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only e13517 Background: Ferumoxytol is an iron oxide nanoparticle, marketed for iron replacement therapy. Off label use as an MRI contrast agent…”
    Get full text
    Journal Article